Abstract:Prostate cancer (PCa) is one of the most prevalent diagnosed malignancies globally. Previous studies have demonstrated that prostaglandin E2 (PGE2) is closely associated with the tumorigenesis and progression of PCa. However, the underlying molecular mechanisms remain unclear and require further investigation. Matrix metalloproteinases (MMPs), receptor activator of nuclear factor‑κB ligand (RANKL) and runt‑related transcription factor 2 (RUNX2), which are involved in cell growth and bone metastasis, are frequently activated or overexpressed in various types of cancer, including PCa. The present study was designed to investigate the associations between PGE2 and the PGE2 receptor EP4, and MMPs, RANKL and RUNX2 in PCa, and to define their roles in PCa cell proliferation and invasion in addition to understanding the molecular mechanisms. The results of western blotting and reverse transcription‑quantitative polymerase chain reaction demonstrated that the protein and the mRNA expression levels of MMP‑2, MMP‑9, RANKL and RUNX2 in PC‑3 cells were significantly upregulated by treatment with PGE2, respectively, and knockdown of these proteins blocked PGE2‑induced cell proliferation and invasion in PC‑3 cells, as determined by Cell Counting Kit‑8 and Matrigel invasion assays, respectively. The effect of PGE2 on the protein and mRNA expression levels was primarily regulated via the EP4 receptor. EP4 receptor signaling activates the cyclic (c)AMP‑protein kinase A (PKA) signaling pathway, and forskolin, an activator of adenylate cyclase (AC), exhibited similar effects to an EP4 receptor agonist on the protein expression, while SQ22536, an inhibitor of AC, inhibited the protein expression. These results confirmed that the AC/cAMP pathway may be involved in EP4 receptor‑mediated upregulation of protein expression. By using a specific inhibitor of PKA, it was also demonstrated that cAMP/PKA was also involved in the EP4 receptor‑mediated upregulation of protein expression. In addition to the signaling pathway involving PKA, the EP4 receptor also exerts activities through activation of Akt kinase. The results in the present study confirmed the hypothesis that EP4 receptor‑mediated protein expression in PCa cells that were pretreated with a specific inhibitor of phosphatidylinositol 3‑kinase (PI3K) was significantly inhibited. In conclusion, the results of the present study indicate that PGE2 significantly upregulated the mRNA and protein expression levels of the MMP‑2, MMP‑9, RANKL and RUNX2, and the EP4 receptor was involved in the cell proliferation and invasion of PCa via the cAMP‑PKA/PI3K‑Akt signaling pathway. These results may provide novel insight into potential therapeutic strategies for the prevention and treatment of PCa.

Prostaglandin E2 Induces Stromal Cell-Derived Factor-1 Expression in Prostate Stromal Cells by Activating Protein Kinase A and Transcription Factor Sp1.

Prostaglandin E2 Mediates Up-regulation of ERRα Expression with BPH-1 Condition Medium in Prostatic Stromal Cells

Up-regulation of MMP-2 Expression by Estradiol via TGFβ1 in Prostate Stromal Cells

Prostaglandin E2 stimulates S100A8 expression by activating protein kinase A and CCAAT/enhancer-binding-protein-beta in prostate cancer cells.

Prostaglandin E2 induced myofibrolast phenotype inversion and interleukin 8 expression in prostate stromal cells

Prostaglandin E2 Receptor EP4 is Involved in the Cell Growth and Invasion of Prostate Cancer Via the Camp‑pka/pi3k‑akt Signaling Pathway.

Prostaglandin E2 (PGE2) Promotes Proliferation and Invasion by Enhancing SUMO-1 Activity Via EP4 Receptor in Endometrial Cancer.

Estrogens Promote Invasion of Prostate Cancer Cells in a Paracrine Manner Through Up-Regulation of Matrix Metalloproteinase 2 in Prostatic Stromal Cells.

Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.

PGE2 Modulates the Transcriptional Activity of ERRa in Prostate Stromal Cells.

Prostaglandin E2 Triggers Cytochrome P450 17α Hydroxylase Overexpression Via Signal Transducer and Activator of Transcription3 Phosphorylation and Promotes Invasion in Endometrial Cancer

The Proliferative Effect of Estradiol on Human Prostate Stromal Cells is Mediated Through Activation of ERK.

Regulation of Proliferation and Differentiation of Prostatic Stromal Cells by Oestradiol Through Prostatic Epithelial Cells in a Paracrine Manner

Both Nongenomic and Genomic Effects Are Involved in Estradiol's Enhancing the Phenotype of Smooth Muscle Cells in Cultured Prostate Stromal Cells.

Cdna Microarray Analysis of Pigment Epithelium-Derived Factor-Regulated Gene Expression Profile in Prostate Carcinoma Cells.

Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblasts.

PGE2 Promotes the Migration of Mesenchymal Stem Cells Through the Activation of FAK and ERK1/2 Pathway

Sdf-1/Cxcr4 Axis Promotes Prostate Cancer Cell Invasion And Bone Metastasis Through P38, Nf-Kappa B And Hif-1 Alpha Pathways

GPR30 Promotes Prostate Stromal Cell Activation Via Suppression of ERα Expression and Its Downstream Signaling Pathway.

Prostaglandin E2 stimulates urokinase-type plasminogen activator receptor via EP2 receptor-dependent signaling pathways in human AGS gastric cancer cells

Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cells